Key Takeaways
- Labster is Kumulus Vape’s production unit for e-liquids and DIY concentrates
- Location/size: Lyon Metropolis, 700 sq m, near the group headquarters
- Equipment: automated lines from CDA; processes include bottling and labeling
- Capacity/status: several million bottles per year (10–100 ml), already operational
- Plans: Labster “signature” launches in 2026; ISO 9001 and Origine France Garantie considered from 2027
2Firsts, Feb 6 2026
According to Boursier.com, Kumulus Vape has launched Labster, its production unit for e-liquids and DIY concentrates. The unit spans 700 square meters in the Lyon Metropolis and is located close to the group’s headquarters.
The report says Labster is equipped with multiple automated production lines supplied by CDA (Constructions d’Automatismes), used to perform bottling and labeling. The facility’s theoretical capacity is described as several million bottles per year in 10 to 100 ml formats, and it is already operational.
As reported, the facility is directly adjacent to the group’s logistics warehouses, allowing finished products to enter distribution flows without additional transport. The group said the move supports inventory management and responsiveness to partners and customers. Kumulus Vape also said it will continue working with manufacturing partners and specialized laboratories to expand its catalog.
Kumulus Vape stated that Labster will support its proprietary brands, including Cigaverte, and improve responsiveness in developing new references. The report adds that the group plans a gradual ramp-up during 2026 with new Labster-branded “signature” products, and from 2027 it is considering steps toward ISO 9001 certification and the Origine France Garantie label for products made by Labster.
Image Source: Boursier.com
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
